This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chai, J. Articles by Weissman, B. E. Search for Related Content PubMed PubMed Citation Articles by Chai, J. Articles by Weissman, B. E.

Loss of the hSNF5 Gene Concomitantly Inactivates p21^CIP/WAF1 and p16^INK4a Activity Associated with Replicative Senescence in A204 Rhabdoid Tumor Cells

¹ Department of Pathology and Laboratory Medicine and ² University of North Carolina-Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina

Requests for reprints: Bernard E. Weissman, Room 32-048, University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599-7295. Phone: 919-966-7533; Fax: 919-966-9673; E-mail: bernard_weissman{at}med.unc.edu.

hSNF5, the smallest member of the SWI/SNF chromatin remodeling complex, is lost in most malignant rhabdoid tumors (MRT). In MRT cell lines, reexpression of hSNF5 induces G₁ cell cycle arrest, elevated p16^INK4a, and activated replicative senescence markers, such as ß-galactosidase (ß-Gal) and plasminogen activator inhibitor-1. To compare the replicative senescence caused by hSNF5 in A204 cells to normal cellular senescence, we examined the activation of both p16^INK4a and p21^CIP/WAF1. Analogous to normal cellular senescence, both p16^INK4a and p21^CIP/WAF1 were up-regulated following hSNF5 restoration. Furthermore, we found that hSNF5 bound the p16^INK4a and p21^CIP/WAF1 promoters, suggesting that it directly regulates transcription of these genes. Using p16^INK4a RNA interference, we showed its requirement for the replicative senescence caused by hSNF5 but not the growth arrest. Instead, p21^CIP/WAF1 remained activated by hSNF5 in the absence of high p16^INK4a expression, apparently causing the growth arrest in A204. Interestingly, we also found that, in the absence of p16^INK4a, reexpression of hSNF5 also increased protein levels of a second cyclin-dependent kinase (CDK) inhibitor, p18^INK4c. However, our data show that lack of hSNF5 does not abrogate cellular responsiveness to DNA damage or growth-inhibitory factors. In summary, our studies suggest that hSNF5 loss may influence the regulation of multiple CDK inhibitors involved in replicative senescence.

This article has been cited by other articles:

				W. Xia, S. Nagase, A. G. Montia, S. M. Kalachikov, M. Keniry, T. Su, L. Memeo, H. Hibshoosh, and R. Parsons BAF180 Is a Critical Regulator of p21 Induction and a Tumor Suppressor Mutated in Breast Cancer Cancer Res., March 15, 2008; 68(6): 1667 - 1674. [Abstract] [Full Text] [PDF]

				M. E. Smith, V. Cimica, S. Chinni, K. Challagulla, S. Mani, and G. V. Kalpana Rhabdoid Tumor Growth is Inhibited by Flavopiridol Clin. Cancer Res., January 15, 2008; 14(2): 523 - 532. [Abstract] [Full Text] [PDF]

				J. Chai, X. Lu, V. Godfrey, C. Fletcher, C. W.M. Roberts, T. Van Dyke, and B. E. Weissman Tumor-Specific Cooperation of Retinoblastoma Protein Family and Snf5 Inactivation Cancer Res., April 1, 2007; 67(7): 3002 - 3009. [Abstract] [Full Text] [PDF]

				C. J. Guidi, R. Mudhasani, K. Hoover, A. Koff, I. Leav, A. N. Imbalzano, and S. N. Jones Functional Interaction of the Retinoblastoma and Ini1/Snf5 Tumor Suppressors in Cell Growth and Pituitary Tumorigenesis Cancer Res., August 15, 2006; 66(16): 8076 - 8082. [Abstract] [Full Text] [PDF]